SOUTHERN JOURNAL OF SCIENCES

Background: Background: Vitamin D plays an essential role in bone health and overall physiological function, and its deficiency is common in children and adolescents with β-thalassemia major (βTM). Iron overload, as reflected by elevated ferritin, may further influence vitamin D status. Aim: This study aimed to evaluate serum vitamin D levels in βTM patients and determine their association with ferritin levels. Methods: A total of 40 βTM patients and 20 age-matched healthy controls (aged 4–25 years) were enrolled between October 2024 and February 2025. Serum vitamin D, calcium, ferritin, and hemoglobin were measured. Statistical analysis, including correlation and logistic regression, was performed using SPSS v.26 to identify predictors of vitamin D deficiency. Results: Vitamin D deficiency was highly prevalent among βTM patients (70%) compared with controls. Patients showed significantly lower vitamin D levels (17.32±1.56) than controls (25.34±1.76). Vitamin D levels were positively correlated with age (r = 0.788), calcium (r = 0.772), and hemoglobin (r = 0.771), and negatively correlated with ferritin (r = −0.517). Logistic regression demonstrated that ferritin >1000 ng/mL strongly predicted vitamin D deficiency (OR = 17.875; 95% CI: 3.258–98.074; p = 0.001), while younger age ( < 10 years) also increased the odds of deficiency (OR = 5.200; p = 0.018). Discussion: D deficiency is a prevalent and intrinsic metabolic disturbance in β-thalassemia major, closely linked to chronic iron overload and elevated ferritin levels. This interplay disrupts hepatic vitamin D hydroxylation, induces inflammation, and contributes to endocrine and skeletal complications, highlighting ferritin as a key predictor of deficiency in these patients. Conclusion: Vitamin D deficiency is highly prevalent in βTM and is strongly associated with elevated ferritin levels, suggesting that iron overload is a significant predictor. Integrating vitamin D assessment into routine monitoring may support better management of disease-related metabolic disturbances in patients with βTM.

E-selectin, as identified (CD62E), is expressed on endothelial cells after stimulation with inflammation cytokines. β-Thalassemia diseases (βT) and early diagnosis are of utmost significance in the entire world population. This study was performed in the Thalassemia Center of the Al-Zahraa Educational Hospital in Al-Najaf Province, Iraq, on sixty-nine with β-thalassemia (54 βT major and 15 βT Intermedia) aged 8-40 years who transfused blood. Compared to 20 healthy volunteers as a control group. In both βT patients and healthy groups were assessed serum E-selectin levels. It was investigated the relationship with RBC, Hb, PCV, WBC, PLT, BMI, splenic status, iron, and ferritin levels. The results revealed a significant (P<0.05) decreased values of HB, RBC, P.C.V, and BMI. In contrast, values of WBC, PLT, Iron, and Ferritin were significantly increased in βT patients as compared to the healthy control groups. A significant (P<0.05) increase in serum E- Selectin level in βT patients (20.55±0.47) ng/ml to compare with the healthy group (9.16±0.50) ng/ml. Furthermore, it was a significant decrease in groups of βT major (19.87±0.42) ng/ml more than in βT intermedia (23±1.42) ng/ml. E-Selectin revealed a significant increase (P<0.05) in progress age and associated with splenectomies and underweight groups compared to splenectomies and the normal weight groups, respectively. Also, E-Selectin levels significantly positively correlated with WBC, PLT value, iron, and Ferritin levels. However, it was no significant with RBC, PCV, Hb. As a conclusion from this study, E- Selectin is an important biomarker in β-thalassemia patients can be identified as the complications associated with iron overload, inflammatory process, and endothelial dysfunction in βT disease. 

Background: Infectious diseases are a global problem, the second human cause of death. Infectious diseases caused by pathogenic bacteria have been treated with a high degree of efficacy. However, even when the 20th century was considered the “golden age” of antibiotics, bacteria developed a different resistance mechanism to antibiotics. In 2017, the WHO issued an alert about 12 bacteria with an urgent need to develop new antibiotics. Aims: The aim of the present review is to analyze the current knowledge of the antibacterial activity of natural extract-based treatments against the pathogens listed by WHO. Methods: A systematic review of the literature in PubMed was performed to search for publications describing the use of natural extracts as antibiotics over bacteria. We focused on the Gram-Negative group. The exclusion criteria consisted of limiting papers on natural extracts tested over the bacteria culture related to eight selected bacteria, according to an alert issued by WHO in 2017, and seven plant extracts. Results: All the Gram-Negative bacteria listed in 2017 by WHO have been treated, with different degrees of advance, with some of the plant extracts and plant-based compounds reviewed. In general, the first approach is using inhibition disks applied over the bacterial biofilm in solid culture media. Discussion: While Salmonellae and P. aeruginosa have been extensively studied, over N. gonorrhoeae, A. baumannii have been tested with fewer natural extracts. Edible herbs are more often used, as well as artemisa and wine byproducts. In all cases, they are in the early stages of study, not being tested in patients at present. Conclusions: Plant extracts and plant-based compounds are effective as antibacterial, with minimal effects on the host cell. Furthermore, they are sustainable, environmentally friendly, and renewable.